LENZ Therapeutics

LENZ Therapeutics is a pharmaceutical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead product is VIZZ, an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia.

Presbyopia impacts almost two billion people globally and more than 120 million people in the US. LENZ Therapeutics is headquartered in San Diego, California, and is backed by multiple blue-chip venture capital investors. Learn more about VIZZ eye drops at www.VIZZ.com